Antimicrobial blue light and photodynamic therapy inhibit clinically relevant β-lactamases with extended-spectrum (ESBL) and carbapenemase activity (2020)
- Authors:
- USP affiliated authors: SELLERA, FABIO PARRA - FMVZ ; BAPTISTA, MAURICIO DA SILVA - IQ ; POGLIANI, FABIO CELIDONIO - FMVZ ; HUENUMAN, NILTON ERBET LINCOPAN - ICB ; ANJOS, CAROLINA DOS - FMVZ ; RIBEIRO, MARTHA SIMÕES - IPEN ; SABINO, CAETANO PADIAL - FCF
- Unidades: FMVZ; IQ; ICB; IPEN; FCF
- DOI: 10.1016/j.pdpdt.2020.102086
- Subjects: TERAPIA FOTODINÂMICA; RESISTÊNCIA MICROBIANA ÀS DROGAS; BACTÉRIAS GRAM-NEGATIVAS; MICROBIOLOGIA; ANTIBIÓTICOS; AZUL DE METILENO; HIDRÓLISE; INIBIDORES DE ENZIMAS
- Keywords: antibiotic resistance; β-lactams; enzymatic inactivation; photoantimicrobial; photoinactivation; visible light
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Photodiagnosis and Photodynamic Therapy
- ISSN: 1572-1000
- Volume/Número/Paginação/Ano: v. 32, p. 1-4 art. 102086, 2020
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
ANJOS, Carolina dos et al. Antimicrobial blue light and photodynamic therapy inhibit clinically relevant β-lactamases with extended-spectrum (ESBL) and carbapenemase activity. Photodiagnosis and Photodynamic Therapy, v. 32, p. 1-4 art. 102086, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.pdpdt.2020.102086. Acesso em: 16 abr. 2024. -
APA
Anjos, C. dos, Sellera, F. P., Ribeiro, M. S., Baptista, M. da S., Pogliani, F. C., Huenuman, N. E. L., & Sabino, C. P. (2020). Antimicrobial blue light and photodynamic therapy inhibit clinically relevant β-lactamases with extended-spectrum (ESBL) and carbapenemase activity. Photodiagnosis and Photodynamic Therapy, 32, 1-4 art. 102086. doi:10.1016/j.pdpdt.2020.102086 -
NLM
Anjos C dos, Sellera FP, Ribeiro MS, Baptista M da S, Pogliani FC, Huenuman NEL, Sabino CP. Antimicrobial blue light and photodynamic therapy inhibit clinically relevant β-lactamases with extended-spectrum (ESBL) and carbapenemase activity [Internet]. Photodiagnosis and Photodynamic Therapy. 2020 ; 32 1-4 art. 102086.[citado 2024 abr. 16 ] Available from: https://doi.org/10.1016/j.pdpdt.2020.102086 -
Vancouver
Anjos C dos, Sellera FP, Ribeiro MS, Baptista M da S, Pogliani FC, Huenuman NEL, Sabino CP. Antimicrobial blue light and photodynamic therapy inhibit clinically relevant β-lactamases with extended-spectrum (ESBL) and carbapenemase activity [Internet]. Photodiagnosis and Photodynamic Therapy. 2020 ; 32 1-4 art. 102086.[citado 2024 abr. 16 ] Available from: https://doi.org/10.1016/j.pdpdt.2020.102086 - Global priority multidrug-resistant pathogens do not resist photodynamic therapy
- Inactivation kinetics and lethal dose analysis of antimicrobial blue light and photodynamic therapy
- Algicidal effect of blue light on pathogenic Prototheca species
- New insights into the bacterial targets of antimicrobial blue light
- Light-based technologies for management of COVID-19 pandemic crisis
- Antimicrobial blue light inactivation of international clones of multidrug-resistant Escherichia coli ST10, ST131 and ST648
- Hypervirulent and hypermucoviscous strains of Klebsiella pneumoniae challenged by antimicrobial strategies using visible light
- Inactivation of milk-borne pathogens by blue light exposure
- Green turtle (Chelonia mydas) cutaneous fibropapillomatosis treatment by photodynamic therapy
- Dermatophilus congolensis
Informações sobre o DOI: 10.1016/j.pdpdt.2020.102086 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 | POG_36_3010045_R.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
